Benchmarking biotech and pharmaceutical product development

被引：6
|
作者：
Drakeman, Donald L. [1 ,2 ]
机构：
[1] Univ Cambridge, Ctr Hlth Leadership & Enterprise, Judge Business Sch, Cambridge, England
[2] Advent Venture Partners, London, England
来源：
NATURE BIOTECHNOLOGY | 2014年 / 32卷 / 07期
关键词：
D O I：
10.1038/nbt.2947
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The biotech sector's record in originating high-priority medicines exceeds that of the pharmaceutical industry, its costs are lower and its products have comparable revenues.
引用
收藏
页码：621 / 625
页数：5
相关论文
共 50 条
  • [21] Pharmaceutical challenges in veterinary product development
    Ahmed, M
    Kasraian, K
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (06) : 871 - 882
  • [22] Information Modeling for Pharmaceutical Product Development
    Zhao, Chunhua
    Hailemariam, Leaelaf
    Jain, Ankur
    Joglekar, Girish
    Venkatasubramanian, Venkat
    Morris, Kenneth
    Reklaitis, Gintaras
    16TH EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING AND 9TH INTERNATIONAL SYMPOSIUM ON PROCESS SYSTEMS ENGINEERING, 2006, 21 : 2147 - 2152
  • [23] Role of nanotechnology in pharmaceutical product development
    Devalapally, Harikrishna
    Chakilam, Ananthsrinivas
    Amiji, Mansoor M.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (10) : 2547 - 2565
  • [24] Pharmaceutical informatics: A novel paradigm for pharmaceutical product development and manufacture
    Zhao, CH
    Joglekar, G
    Jain, A
    Venkatasubramanian, V
    Reklaitis, GV
    European Symposium on Computer-Aided Process Engineering-15, 20A and 20B, 2005, 20a-20b : 1561 - 1566
  • [25] The anticancer drug development pipeline of the pharmaceutical (P) and biotech (B) industries
    Thomas, F. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] The biotech bend in the pharmaceutical industry
    Lalandes, Romain
    Thomas, Anne-Laure
    El Fajoui, Zineb
    Jani, Siavash Ali Madadi
    Ganesan, Balaji
    Le, Philippe
    Mangematin, Vincent
    Amir-Aslani, Arsia
    BIOFUTUR, 2011, (317) : 52 - 53
  • [27] FROM EXPERIENCE - BENCHMARKING NEW PRODUCT DEVELOPMENT FUNDING
    PIERZ, KA
    JOURNAL OF PRODUCT INNOVATION MANAGEMENT, 1995, 12 (01) : 43 - 53
  • [28] Pharmaceutical innovation and advanced biotechnology in the biotech-pharmaceutical industry for antibody- drug conjugate development
    Ma, Qi
    Durga, Puro
    Wang, Frederick X. C.
    Yao, Hang-Ping
    Wang, Ming-Hai
    DRUG DISCOVERY TODAY, 2024, 29 (08)
  • [29] DEVELOPMENT OF A PRODUCT FAMILY ANALYSIS TOOLKIT FOR SYSTEMATIC BENCHMARKING
    Jain, Avanti
    Sarnobat, Rahul
    Simpson, Timothy W.
    PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING TECHNICAL CONFERENCES AND COMPUTERS AND INFORMATION IN ENGINEERING CONFERENCE 2010, VOL 1, PTS A AND B, 2010, : 857 - 867
  • [30] Risk management in the pharmaceutical product development process
    Hulbert M.H.
    Feely L.C.
    Inman E.L.
    Johnson A.D.
    Kearney A.S.
    Michaels J.
    Mitchell M.
    Zour E.
    Journal of Pharmaceutical Innovation, 2008, 3 (4) : 227 - 248
12345